ClinConnect ClinConnect Logo
Search / Trial NCT06612957

A Randomized Controlled Study of Uterine Incision Diverticulum Repair vs. no Repair During Second/Third Cesarean Section

Launched by SHANGHAI FIRST MATERNAL AND INFANT HEALTH HOSPITAL AFFILIATED TO TONGJI UNIVERSITY MEDICAL SCHOOL · Sep 23, 2024

Trial Information

Current as of June 21, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a surgical procedure called uterine incision diverticulum repair during a second or third cesarean section. The main goal is to find out if this procedure can help reduce heavy menstrual bleeding (called menorrhagia) and to ensure that it is safe for women undergoing repeat cesarean deliveries. Participants will be randomly assigned to either the group that receives the repair during their cesarean section or to a control group that has a standard cesarean section without the repair.

To be eligible for this study, women must be at least 18 years old, pregnant with one baby, and have had a previous cesarean section. They also need to have a specific condition called uterine incision diverticulum, which is identified by imaging tests. After the surgery, participants will return to the hospital for a check-up 42 days later and will be followed up by phone 6 to 12 months after their operation. It’s important to know that the trial is not yet recruiting participants, so there’s no need to sign up immediately.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women aged ≥18 years, gestational age ≥37 weeks, singleton pregnancy, previous lower segment cesarean section, second or third cesarean section, and diagnosed with uterine incision diverticulum by imaging before or during early pregnancy.
  • Exclusion Criteria:
  • Preoperative indications of placenta accreta or previa, interdelivery interval less than 18 months from the last cesarean section, history of other uterine surgeries, and severe obstetric or medical complications requiring emergency care.

About Shanghai First Maternal And Infant Health Hospital Affiliated To Tongji University Medical School

Shanghai First Maternal and Infant Health Hospital, affiliated with Tongji University Medical School, is a leading institution dedicated to advancing maternal and child health through innovative clinical research and high-quality patient care. With a commitment to improving health outcomes for mothers and infants, the hospital leverages its academic affiliation to integrate cutting-edge medical practices with comprehensive clinical trials. The institution fosters a collaborative environment that promotes interdisciplinary research, ensuring that its studies are grounded in scientific rigor and aimed at addressing the most pressing health challenges faced by families today.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported